Skip to main content
Log in

Escitalopram best choice for MDD in Italy

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • C-QUALITY: cost and quality-of-life pharmacoeconomic analysis of antidepressants used in major depressive disorder in the regional Italian settings of Veneto and Sardinia. ClinicoEconomics and Outcomes Research : 3 Dec 2013. Available from: URL: http://dx.doi.org/10.2147/CEOR.S52063

Download references

Additional information

* Cost and Quality of Life Pharmacoeconomic Analysis on MDD in Italy

** The study was financially supported by an unrestricted grant from Lundbeck Italy SpA.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Escitalopram best choice for MDD in Italy. PharmacoEcon Outcomes News 693, 6 (2013). https://doi.org/10.1007/s40274-013-0933-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-013-0933-1

Navigation